Antibiotics | Susceptibility (N = 60) | Resistance |
---|---|---|
Imipenem | 56 (93.3%) | 6.7% |
Meropenem | 55 (91.7%) | 8.3% |
Ertapenem | 55 (91.7%) | 8.3% |
Amikacin | 54 (90.0%) | 10.0% |
Tigecycline | 48 (80.0%) | 20.0% |
Cefperazone-sulbactam | 44 (73.3%) | 26.7% |
Piperacillin-tazobactam | 40 (66.7%) | 33.3% |
Gentamicin | 39 (65.0%) | 35.0% |
Ceftazidime | 38 (63.3%) | 36.7% |
Cefepime | 37 (61.7%) | 38.3% |
Aztreonam | 34 (56.7%) | 43.3% |
Amoxicillin-clavulanic acid | 33 (55.0%) | 45.0% |
Ceftriaxone | 31 (51.7%) | 48.3% |
Levofloxacin | 30 (50.0%) | 50.0% |
Minocycline | 30 (50.0%) | 50.0% |
Sulfamethoxazole trimethoprim | 29 (48.3%) | 51.7% |
Cefuroxime | 27 (45.0%) | 55.0% |
Ciprofloxacin | 26 (43.3%) | 56.7% |